Feature Articles

Feature Articles

ASH Clinical News takes a deeper look at hot topics in medicine

Adapting to Changes in Practice-Based Hematology

It is not news that the practice of hematology today looks much different than it did in 1958 when the American Society of Hematology...

Efforts to Protest High Cancer Drug Prices Underway

There is an inconvenient truth when it comes to the cost of new cancer therapies in the United States: The median U.S. household income...

Mind the Gap: The ACA’s Medicaid Expansion Provision Leaves Vulnerable Patients Uncovered

A key element of the Patient Protection and Affordable Care Act (ACA) was the expansion of the Medicaid program, designed to provide financial assistance...

The ACA Out-of-Pocket Limit: Good and Bad News for Hematology Patients

Although the act sets limits on the out-of-pocket expenses a patient might face, many costs associated with hematologic care may fall outside of the...

NOACs: The Novel Kids on the Block

The time has come for clinicians to turn to novel oral anticoagulant agents for the first-line prevention of stroke and systemic embolism in patients with...

Who Cares About What Patients Think? The FDA, Insurance Payers, Researchers… Maybe You Should...

While patient-reported outcomes (PROs) are nothing new in the field of medicine, they may now be newly appreciated. The U.S. Food and Drug Administration (FDA)...

Defining “Value” in Value-Based Medicine: A Work in Progress

Achieving optimal patient outcomes is still one of the most important aspects of health care. In recent years, a new goal – and one...

Adapting to Scientific Meeting Climate Change

Presenting scientific research at a major – or even medium-sized – scientific meeting in 2015 is vastly different than it was even 10 years...

Physicians Still Foggy on Accuracy of Sunshine Act Data

On September 30, the Centers for Medicare & Medicaid Services (CMS) released the first round of Open Payments data. More than 4 million payments...

New IMWG Diagnostic Criteria Allows Earlier Diagnosis

Updates Represent a “Paradigm Shift” for Multiple Myeloma Treatment Unlike other malignancies, the disease definition of multiple myeloma is clinicopathological: not only must myeloma be...
Advertisement

Current Issue

June 2019, Volume 5, Issue 7

This issue features a debate about new treatment options for beta-thalassemia, a look at what’s driving skyrocketing drug prices in myeloma, and more.